1. Appel L. J., Frohlich E. D., Hall J. E., et al. AHA Presidential Advisory. The Importance of Population-Wide Sodium Reduction as a Means to Prevent Cardiovascular Disease and Stroke. A Call to Action From the American Heart Association. Circulation 2011; 123:1138–43.
2. Guyton A. C., Coleman T. G., Cowley A. W. Brief Reviews: A Systems Analysis Approach to Understanding Long-Range Arterial Blood Pressure Control and Hypertension. Circ. Res 1974; 35:159–76.
3. Hall J. E. The Kidney, Hypertension, and Obesity. Hypertension 2003; 41:625–33.
4. Guyton A. C. Blood Pressure Control Special Role of the Kidneys and Body Fluids.Science1991; 252; 5014:1813–6.
5. Lavoie J. L., Sigmund C. D. Minireview: Overview of the Renin-Angiotensin System — An Endocrine and Paracrine System. Endocrinology 2003; June; 144 (6):2179–83.
6. Guyton A. C. Renal function curve-a key to understanding the pathogenesis of hypertension.Hypertension 1987; 10:1–6.
7. Kimura G., Saito F., Kojima S., et al. Renal function curve in patients with secondary forms of hypertension. Hypertension 1987; 10:11–5.
8. Adrogué H. J., Madias N. E., Sodium and Potassium in the Pathogenesis of Hypertension.N Engl J Med 2007; 356:1966–78.
9. Kimura G. Kidney and Circadian Blood Pressure Rhythm.Hypertension 2008; 51:827–8.
10. Guyton A. C. Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J PhysiolRegulIntegr Comp Physiol 1990; November 1; 259: R865-R877.
11. Strazzullo P., Galletti F., Barba G. Altered Renal Handling of Sodium in Human Hypertension: Short Review of the Evidence. Hypertension 2003; 41:1000–5.
12. O’Rourke M. F., Safar M. E. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46:200–4.
13. London G. M., Pannier B. Arterial functions: how to interpret the complex physiology. Nephrol. Dial. Transplant 2010; December 1; 25 (12):3815–23.
14. Kaplan N. M. Kaplan’s Clinical Hypertension. 9th ed., Philadelphia/Baltimore/NewYork/London/Buenos Aires/Hong Kong/Sydney/Tokyo: Lippincott Williams & Wilkin. A WoltersKlummer Company USA. 2006, 50–121.
15. Reinhardt H. W., Seeliger E. Toward an Integrative Concept of Control of Total Body Sodium. Physiology 2000: 1: 15; 319–25.
16. Rodriguez-Iturbe B., Vaziri N. D. Salt-sensitive hypertension — update on novel findings Nephrol Dial Transplant 2007 22:992–5.
17. Weder A. B. and Schork N. J. Adaptation, allometry, and hypertension. Hypertension 1994;24:145–56.
18. Meneton P., Jeunemaitre X., de Wardener H. E. et al. Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases. Physiol Rev 2005; 85:679–715.
19. Zandi-Nejad K., Luyckx V. A., Brenner B. M. Adult Hypertension and Kidney Disease. The Role of Fetal Programming.Hypertension 2006; 47:502–8.
20. Yu H. C. M., Burrell L. M., Black M. J., et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998; 98:2621–8.
21. Bidani A. K., Griffin K. A. Pathophysiology of Hypertensive Renal Damage: Implications for Therapy.Hypertension 2004; 44:595–601.
22. Keller G., Zimmer G., Mall G., et al. Nephron Number in Patients with Primary Hypertension.N Engl J Med 2003; 348; № 2:101–8.
23. Sanders P. W. Salt Intake, Endothelial Cell Signaling, and Progression of Kidney Disease Hypertension 2004; February 1; 43 (2):142–6.
24. Pavenstadt H., Kriz W., Kretzler M. Cell Biology of the glomerular podocyte. Physiol Rev 2003; 83:253–307.
25. Benstein J. A., Feiner H. D., Parker M., et al. Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol 1990; (6 Pt 2); 258: F1675–F1681.
26. Ying W-Z, Sanders P. W. Dietary salt modulates renal production of transforming growth factor-
27. Frohlich E. D. The Salt Conundrum A Hypothesis.Hypertension.2007; 50:161–6.
28. Ritz E. The Kidney: Both Culprit and Victim. Hypertension 2009; 54:25–26.
29. Weinberger M. H., Fineberg N. S. Sodium and volume sensitivity of blood pressure. Age and pressure change over time.Hypertension1991; 18; 67–71.
30. Weinberger M. H. Salt Sensitivity of Blood Pressure in Humans.Hypertension 1996; 27:481–90.
31. Reuter S., Bussemaker E., Hausberg M., et al. Effect of excessive salt intake: role of plasma sodium. Current Hypertension Report 2009 April; vol.11; № 2: 91–7.
32. Fukuda M., Mizuno M., Yamanaka T., et al. Pressure Dips During the Night Patients With Renal Dysfunction Require a Longer Duration Until Blood. Hypertension 2008; 52: 1155–60.
33. Schmidlin O., Forman A., Sebastian A., et al. What Initiates the Pressor Effect of Salt in Salt-Sensitive Humans? Observations in Normotensive Blacks.Hypertension 2007; 49:1032–39.
34. Schmidlin O., Forman A., Tanaka M., et al. NaCl-induced renal vasoconstriction in salt-sensitive African-Americans: Antipressor and hemodynamic effects of potassium bicarbonate. Hypertension 1999; 33:633–9.
35. Chiolero A., Würzner G., Burnier M. Renal determinants of the salt sensitivity of blood pressure. Nephrol Dial Transplant 2001; 1; 16:452–8.
36. Chelliah R., Sagnella G. A., Markandu M. D., et al. Urinary protein and essential hypertension in black and in white people. Hypertension 2002; 39:1064–70.
37. Pontremoli R., Leoncini G., Viazzi F., et al. Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension.J Am SocNephrol 2005; 16: S39–S41;
38. Hillege H. L., Fidler V., Diercks G. F. H., et al. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population. Circulation 2002; 106:1777–82.
39. Ärnlöv J., Evans J. C., Meigs J. B., et al. Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and NondiabeticIndividuals.The Framingham Heart Study. Circulation 2005; 112:969–75
40. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., et al. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989; 32:219–26.
41. Cianciaruso B., Bellizzi V., Minutolo R. et al. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 1998; 24:296–301.
42. He F. J., Marciniak M., et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 2009; 54:482–8.
43. Swift P. A., Markandu N. D., et al. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005; 46:308–12.
